Understanding OUR Cytokine-Based Immunotherapy Candidates Our motivation extends to advancing a robust portfolio of programs geared toward growing the horizons of cytokine-based immunotherapy, especially for cancers where procedure alternatives remain limited. Utilize the links below to learn far more about our portfolio of cytokine-based immunotherapy candidates. Explore Our Pipeline https://financefeeds.com/atfx-illuminates-the-future-with-2025-annual-gala-dinner/